INTERNATIONAL PATENT: HUMANWELL PHARMACEUTICAL US, INC. FILES APPLICATION FOR "PRODRUGS OF SOMATOSTATIN RECEPTORS SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS"

GENEVA, Jan. 20 -- HUMANWELL PHARMACEUTICAL US, INC. (421 Sovereign CourtBallwin, Missouri 63011) filed a patent application (PCT/US2025/037061) for "PRODRUGS OF SOMATOSTATIN RECEPTORS SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS" on Jul 10, 2025. With publication no. WO/2026/015686, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHAO, Shuo (c/o HUMANWELL PHARMACEUTICAL US421 Sovereign CourtBallwil, Missouri 63011), BOWROJU, Suresh Kuarm (c/o HUMANWELL PHARMACEUTICAL US421 Sovereign CourtBallwin, Missouri 63011), LI...